Getty Images / FangXiaNuo

Looking for a session on genomics technology? What about emerging diagnostics or point-of-care (POC) testing? The 2020 AACC Annual Scientific Meeting & Clinical Lab Expo offers content across the spectrum of clinical laboratory practice, enabling attendees to dive deeper into core aspects of their practice or to explore issues they are not as familiar with. “

The pathways are just one way to help guide attendees to various topics which may be directly relevant to them,” said Paul Jannetto, PhD, DABCC, FAACC, chair of the Annual Meeting Organizing Committee. “If someone is looking for more education/information in data analytics, genomics, or toxicology/TDM, they can quickly identify which scientific sessions or AACC University options exist for that specialty area.” 

Chart a course based on your needs and interests first, then add other sessions that might be outside your comfort zone to freshen your skills.


Novel Coronavirus

Pandemic Preparedness: The Role of Clinical Laboratories and Public Health in Controlling Outbreaks Representing a Global Health Threat (32113)

SARS-CoV-2 Virology, Kinetics, Diagnostics and Containment (32115)

SARS-CoV-2 Vaccine Basics—Current State of Affairs (33114)

Antibody and Antigen Testing for SARS-CoV-2: Where Are We Now? (32454)


Data Analytics

Data-Driven Quality Assessment (35222)

How Clinical Laboratory Data is Impacting the Future of Healthcare? (34104)

Integrating Technology, Data Analytics and the Laboratory Value Pyramid for High Value Patient Outcomes (35226)


Point-of-Care Testing

Point-of-Care Testing Boot Camp

Governance in the Increasingly Complex World of Point-of-Care Testing (32104)

The Total Testing Process: Collaboration Between Laboratory Medicine and Emergency Medicine to Ensure Quality Testing (34230)

Management of Point-of-Care Testing: An AACC Academy Guidance Document (33107)


Emerging Diagnostics

Emerging Applications of Multi-omic Mass Spectrometry (32225)

Current Landscape of Clinical Diagnostics and Emerging Technologies in the U.S. and China (34223)

The Future Is Near: Blood Tests for Alzheimer’s and Related Neurodegenerative Diseases (35230)

Stroke Biomarkers: From Discovery to Diagnosis, Prognosis, and Guidance of Therapy (32233)



Tumor Mutation Burden: A Potential Novel Biomarker for Therapeutic Selection (34113)

If at First You Don’t Succeed: An Interactive Case-Based View of Emerging Molecular Technologies (35225)

Transform Passive Laboratory Testing to Active Consultation in Clinical Pharmacogenomic Service (34234)

Laboratory Automation in Molecular Diagnostics for Infectious Diseases and Oncology (32106)



Is Therapeutic Drug Monitoring for Organ Transplantation on the Bleeding Edge? (34106)

Fentanyl and Fentanyl Analogs: From Overdose, to Outbreaks, to Laboratory Detection (34103)

More Than Opioids: New Trends in Adolescent and Young Adult Substance Abuse Testing (32229)

A Tale of Using Seized Drugs, DUID, and Postmortem Cases to Keep the Laboratory at the Front-Line (34221)